Penn Medicine MD
@PennMDForum
Followers
6K
Following
8K
Media
2K
Statuses
7K
We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.
Philadelphia, PA
Joined March 2010
Alexander W. R. Bridges, MD, a Cardiothoracic Surgeon @LGHealth, dives into advanced #Afib treatment discussing causes, risk factors, pathophysiology, & treatments like the Cox-Maze 3 procedure, left atrial appendage removal & more advances @PennCardiology
0
1
1
Congratulations to @johnplastaras and @michelleiocolan on your innovation award!.
Celebrate our new award winners who are accelerating RT for non-cancerous conditions @carmenbergom @WashUMedRadOnc @KhashiFattah @BobTimmermanMD @UTSW_RadOnc @michelleiocolan @johnplastaras @PennRadOnc @sueyom @UCSFRadOnc .More on their pioneering research
0
0
1
RT @PennMedicine: Congratulations to Dr. Nancy Speck, whose research has provided critical knowledge to help us understand how certain bloo….
0
3
0
Last week, Penn Aorta Center Director Dr. Desai and Vascular Director Dr. Wang hosted an Aorta Summit Dinner Meeting sharing expertise, resources, and the opportunity to collaborate in comprehensive aortic disease patient care @penncardiology @pennsurgery
1
2
7
RT @PennCancer: In a @BCRFcure webinar, @DrLolaFayanju said that post-menopausal #BreastCancer is more likely in White women, but “more lik….
0
2
0
RT @CharuAggarwalMD: 🚨 Don’t miss our educational session today!.📍 E450A, 8 AM CT.🎤 @kaushalpar @BRicciutiMD.@ASCO #ASCO25 @OncoAlert #LCSM….
0
13
0
RT @PennCardiology: ICYMI ➡️ recent @PennMedicine clinical trials found that asynchronous semiautomated referrals for pharmacist involvemen….
0
1
0
#ASCO25 Does neoadjuvant immunotherapy have a place in earlier-stage melanoma? Giorgos Karakousis, MD, shares the results of a Phase II study on the closing day of @ASCO. Abstract 9502. @PennMedMelanoma @PennSurgery
0
3
11
RT @BryanDChoi: Congrats @StephenBagleyMD @DrORourke2 and colleagues @PennCancer on their manuscript in @NatureMedicine showing safety and….
0
31
0
RT @PC3Innovation: #PC3IatASCO: @chefaleixomd, @ramsedhom, @efratdotan, & @ravi_b_parikh evaluating implementation of the Practical #Geriat….
0
3
0
RT @CharuAggarwalMD: Last night at the @PennCancer reception! Wonderful representation @ASCO #ASCO25 and we had with several faculty, fello….
0
10
0
RT @PennCancer: Join us either in person or virtually for the Updates in Oncology 2025 meeting on 6/11, which will address the questions th….
0
1
0
RT @PennMedicine: #ASCO25: @StephenBagleyMD on CAR T cell for glioblastoma: “The treatment changed the trajectory of their disease.” Now in….
0
5
0
RT @PennNSG: New in @NatureMedicine, our researchers have found that a dual-target CAR T-cell therapy approach shows promise for slowing tu….
0
27
0
RT @CharuAggarwalMD: The best thoracic/HN section! So grateful to work with each one of these fabulous individuals.@ASCO #ASCO25 @PennMedic….
0
3
0
Staci Kallish, DO, part of the Penn Aorta Center, highlights the importance of identifying monogenic causes of aortic disease to guide monitoring specific blood vessels, surgical decisions, and screening at-risk family members. @PennCardiology .
0
1
2
Visit @PennCancer at #ASCO25 at booth #11000 to learn about job opportunities and advances in oncology taking place at Penn Medicine. We're hiring in Philly, Lancaster, and Princeton!
0
0
5
RT @CharuAggarwalMD: Fantastic representation of #Thoracic oncology @ASCO #ASCO25 posters! . @BenBleibergMD @MMarmarelis @CoreyLangerMD @Lo….
0
7
0
RT @DrORourke2: Our full P1 trial paper now available @NatureMedicine for treatment of recurrent #Glioblastoma completed at @PennMDForum @P….
0
3
0